Cardioloog Marnix von Kemp
ActiveSummary
The computed 12-month bankruptcy probability of Cardioloog Marnix von Kemp is 3.1% (moderate). The 2024 annual accounts show equity of €85k and a net result of €64k. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2024
80
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency100▲+31
Growth78
Track record94
Bankruptcy probability, 12 months
3.1%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €6k at 30 days acceptable
Liquidity ample (current ratio 5.12 against 2.7 in 2023; short-term debt: 19.5% and cash: 63.5% of total assets), and 22% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Three signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 25-08-2025, 25 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 2 filingsDeviation from the deadline
2025
not confirmed
2024
25 d late
2023
28 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Equity
€85k▲ 298%
2023 · €21k
2023: €21k
2023 → 2024
Total assets
€109k▲ 127%
2023 · €48k
2023: €48k
2023 → 2024
Net result
€64k▲ 203%
2023 · €21k
2023: €21k
2023 → 2024
Working capital
€88k▲ 189%
2023 · €30k
2023: €30k
2023 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20232024Trend
Equity€21k-€85k▲ 298%
Operating result€27k-€81k▲ 202%
Net result€21k-€64k▲ 203%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result rises in 2024; 2024 is 202% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Equity and liabilities €109k
Equity
€85k ▲ 298%
Debt
€24k ▼ 10.5%
Debt's share of the balance-sheet total falls from 55.6% to 22.0%. Equity is higher and debt is lower.
Key figures and ratios
Current ratio
5.12▲
2023 · 2.70
Debt to equity
0.28▼
2023 · 1.25
ROE
74.9%▼
2023 · 98.6%
ROA
58.5%▲
2023 · 43.8%
Debt ≤ 1 year
€21k▲
2023 · €18k
Income taxes
€17k▲
2023 · €6k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 28 lines
Balance sheet
Code20232024
Assets
Total assets20/58€48k€109k▲
Current assets29/58€48k€109k▲
Amounts receivable within one year40/41€3k€2k▼
Other amounts receivable41€3k€2k▼
Cash at bank and in hand54/58€22k€69k▲
Deferred charges and accrued income490/1€23k€38k▲
Equity and liabilities
Total equity and liabilities10/49€48k€109k▲
Equity10/15€21k€85k▲
Contributions10/11€300€300=
Reserves13€21k€85k▲
Distributable reserves133€21k€85k▲
Amounts payable17/49€27k€24k▼
Amounts payable within one year42/48€18k€21k▲
Taxes, remuneration and social security45€18k€21k▲
Taxes450/3€6k€17k▲
Remuneration and social security454/9€12k€4k▼
Accrued charges and deferred income492/3€9k€3k▼
Income statement
Code20232024
Gross operating margin9900€27k€81k▲
Operating profit (loss)9901€27k€81k▲
Financial income75/76B€22€22▼
Recurring financial income75€22€22▼
Profit (loss) for the period before taxes9903€27k€81k▲
Income taxes67/77€6k€17k▲
Profit (loss) for the period9904€21k€64k▲
Profit (loss) for the period to be appropriated9905€21k€64k▲
Appropriation of the result
Profit (loss) to be appropriated9906€21k€64k▲
Transfer to equity691/2€21k€64k▲
To other reserves6921€21k€64k▲
The notes to these accounts (2 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
25-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 25 days late
2024
03-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
NBB filing
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wemmel · 1 establishment unit since 2023
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Steenweg op Brussel 991780 WemmelGround area
484 m²
Building footprint
171 m²
Volume, LiDAR
1,173 m³
Parcel 22662B0540/00W002, Flanders · tallest building 12.1 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Cardioloog Marnix von Kemp
since 20232.349.808.766
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 22662B0540/00W002 | Flanders | 484 m² | 1 · 171 m² | 12.1 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded15-09-2023
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 2 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.